Pharma Reviews: Why Abbot India Outperformed Pharma Peers

By comparison, the benchmark Nifty Pharma Index fell nearly 9 and the drugmaker's most Indian peers declined. The company's outperformance can ...
Read more: Why Abbot India Outperformed Pharma Peers